FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Fortrea Holdings Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.42−0.07 (-0.31%)
Close on Oct 19, 2026
- Market cap
- $2.13B
- P/E (TTM)
- –
- Dividend yield
- –
Fortrea Holdings Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| Clinical Services Segment | $2.72B | $2.70B | $2.84B | $2.84B | $2.76B | 100.0% | +1.0% |
| Enabling Services | – | – | $269.50M | $270.70M | $294.00M | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | YoY |
|---|---|---|---|---|---|---|
| Clinical Services Segment | -$872.60M | -$161.90M | $32.00M | $187.10M | $339.50M | +439.0% |
| Enabling Services | – | – | $11.40M | $24.40M | $39.00M | – |
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|
| North America | $1.29B | $1.27B | $1.40B | $1.42B | $1.65B | 47.4% | +1.6% |
| Europe | $851.70M | $800.00M | $827.50M | $841.90M | $868.40M | 31.3% | +6.5% |
| Other | $582.10M | $626.90M | $616.60M | $579.60M | $539.50M | 21.4% | -7.1% |
From the segment and revenue-disaggregation notes of Fortrea's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.